These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30090093)

  • 21. Mediators Go Together: High Production of CXCL9, CXCL10, IFN-γ, and TNF-α in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
    Neco HVPDC; Teixeira VGDS; da Trindade ACL; Magalhães PMR; de Lorena VMB; Castellano LRC; de Souza JR; Vasconcelos LR; de Moura PMMF; de Morais CNL
    AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1134-1139. PubMed ID: 28648091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-Analysis of HTLV-1-Infected Patients Identifies CD40LG and GBP2 as Markers of ATLL and HAM/TSP Clinical Status: Two Genes Beat as One.
    Fukutani ER; Ramos PIP; Kasprzykowski JI; Azevedo LG; Rodrigues MMS; Lima JVOP; de Araújo Junior HFS; Fukutani KF; de Queiroz ATL
    Front Genet; 2019; 10():1056. PubMed ID: 31781157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
    Lezin A; Buart S; Smadja D; Akaoka H; Bourdonné O; Perret-Liaudet A; Césaire R; Belin MF; Giraudon P
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):965-72. PubMed ID: 10890358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.
    Coler-Reilly ALG; Sato T; Matsuzaki T; Nakagawa M; Niino M; Nagai M; Nakamura T; Takenouchi N; Araya N; Yagishita N; Inoue E; Yamano Y
    Neurotherapeutics; 2017 Oct; 14(4):1084-1094. PubMed ID: 28536850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net).
    Coler-Reilly AL; Yagishita N; Suzuki H; Sato T; Araya N; Inoue E; Takata A; Yamano Y
    Orphanet J Rare Dis; 2016 May; 11(1):69. PubMed ID: 27225443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy.
    Kira J; Fujihara K; Itoyama Y; Goto I; Hasuo K
    J Neurol Sci; 1991 Nov; 106(1):41-9. PubMed ID: 1779238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid neopterin, but not osteopontin, is a valuable biomarker for the treatment response in patients with HTLV-I-associated myelopathy.
    Nagai M; Tsujii T; Iwaki H; Nishikawa N; Nomoto M
    Intern Med; 2013; 52(19):2203-8. PubMed ID: 24088752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T
    Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Moritoyo T; Izumo S; Moritoyo H; Tanaka Y; Kiyomatsu Y; Nagai M; Usuku K; Sorimachi M; Osame M
    J Neurovirol; 1999 Jun; 5(3):241-8. PubMed ID: 10414514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.